Analyze Diet
Veterinary medicine international2022; 2022; 6559193; doi: 10.1155/2022/6559193

Serological Evidence of Antibodies to Rift Valley Fever Virus in Wild and Domestic Animals in Bauchi State, Nigeria.

Abstract: Rift Valley fever (RVF) is an arthropod-borne zoonotic disease responsible for severe outbreaks in livestock and humans with concomitant economic losses in many countries in sub-Saharan Africa. The study, therefore, investigated the seroprevalence of the Rift Valley fever virus (RVFV) among wild and domestic animals. Blood samples were collected between 2013 and 2015 from 106 wild animals, 300 cattle (), and 200 horses (), respectively, in Yankari Game Reserve (YGR) and Sumu Wildlife Park (SWP) in Bauchi state, Nigeria. Harvested sera from blood were evaluated for the presence of anti-RVFV IgM/IgG antibodies. The overall seroprevalence in cattle was 11.3% ( = 0.677; 95% CI: 0.624-0.730) and in wildlife was 8.5% ( = 0.006; 95% CI: 0.00-0.60). The diversity of wildlife species sampled indicated seropositivity of 36.0% in waterbuck (), 25.0% in elephant (), 12.5% in eland (), and 8.3% in wildebeest (). Whereas, samples from zebra (), kudu (), and hartebeest () did not show detectable antibodies to RVFV, and seroprevalence in female (15.0%) wildlife species was higher than in males (4.5%) ( = 0.061). Classification of cattle into breed and sex showed no significant difference in seropositivity. Seropositivity of 12.0% was observed in White Fulani, 12.1% in Red Bororo, and 7.8% in Sokoto Gudali breeds of cattle ( = 0.677). Whereas, seropositivity of 13.6% was observed in females and 6.4% observed in males ( = 0.068). This study indicated the presence of antibodies to RVFV among some wild animals and cattle in the absence of a reported outbreak in the study area. The circulation of RVFV in the study area may pose a significant health risk to livestock, wildlife, and humans. Therefore, surveillance for RVFV should be intensified targeting mosquito vectors and humans in Bauchi state, Nigeria.
Publication Date: 2022-03-16 PubMed ID: 35340539PubMed Central: PMC8942677DOI: 10.1155/2022/6559193Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research looked at the presence of Rift Valley fever virus (RVFV) in wild and domestic animals in Bauchi State, Nigeria. It found that there were antibodies to the virus in some animals, an indication that the disease was present in the area.

Study Overview

  • The research focused on Rift Valley fever (RVF), an insect-borne disease that can affect both animals and humans, causing severe health issues and economic damage in many countries in sub-Saharan Africa.
  • The scientists set out to study the prevalence of the RVF virus (RVFV) in wild and domestic animals, using blood samples taken from a variety of species in Bauchi State, Nigeria, between 2013 and 2015.

Methodology

  • Blood samples were collected from 106 wild animals, 300 cattle, and 200 horses respectively, in the Yankari Game Reserve (YGR) and Sumu Wildlife Park (SWP).
  • The blood was tested for the presence of anti-RVFV IgM/IgG antibodies, which would indicate an immune response to infection with the virus.

Results

  • The overall seroprevalence, or the level at which the virus was present, was 11.3% in cattle and 8.5% in wild animals.
  • Among wild animals, seropositivity (the presence of antibodies) varied between species. The waterbuck had the highest rate at 36.0%, followed by the elephant (25.0%), the eland (12.5%) and the wildebeest (8.3%).
  • There were no detectable antibodies in the zebra, kudu, and hartebeest.
  • In female wildlife, the seroprevalence rate was higher (15.0%) than in males (4.5%).
  • When the data was divided by breed and sex for the cattle, there were no significant differences in seropositivity, with rates of 12.0% in White Fulani, 12.1% in Red Bororo, and 7.8% in Sokoto Gudali cattle. Among female cattle, seropositivity was 13.6%, and in males, it was 6.4%.

Conclusions and Recommendations

  • The detection of antibodies to the RVFV, even in the absence of reported outbreaks, suggests the virus is present in Bauchi State, Nigeria.
  • The presence of RVFV poses health risks to livestock, wildlife, and humans in the area.
  • The researchers therefore recommended increased surveillance for RVFV, particularly focusing on mosquito vectors, which spread the disease, and on potential human cases.

Cite This Article

APA
Atuman YJ, Kudi CA, Abdu PA, Okubanjo OO, Wungak Y, Ularamu HG, Abubakar A. (2022). Serological Evidence of Antibodies to Rift Valley Fever Virus in Wild and Domestic Animals in Bauchi State, Nigeria. Vet Med Int, 2022, 6559193. https://doi.org/10.1155/2022/6559193

Publication

ISSN: 2090-8113
NlmUniqueID: 101524203
Country: United States
Language: English
Volume: 2022
Pages: 6559193
PII: 6559193

Researcher Affiliations

Atuman, Y J
  • National Veterinary Research Institute Vom Outstation Laboratory, Bauchi, Nigeria.
Kudi, C A
  • Department of Veterinary Medicine, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria.
Abdu, P A
  • Department of Veterinary Medicine, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria.
Okubanjo, O O
  • Department of Veterinary Parasitology and Entomology, Ahmadu Bello University, Zaria, Nigeria.
Wungak, Y
  • Viral Research Division, National Veterinary Research Institute, Vom, Nigeria.
Ularamu, H G
  • Viral Research Division, National Veterinary Research Institute, Vom, Nigeria.
Abubakar, A
  • Force Animal Branch Department, Nigeria Police Force Headquarters, Abuja, Nigeria.

Conflict of Interest Statement

The authors declare that they have no conflicts of interest.

References

This article includes 53 references
  1. Jori F, Alexander KA, Mokopasetso M, Munstermann S, Moagabo K, Paweska JT. Serological Evidence of Rift Valley Fever Virus Circulation in Domestic Cattle and African Buffalo in Northern Botswana (2010-2011).. Front Vet Sci 2015;2:63.
    doi: 10.3389/fvets.2015.00063pmc: PMC4672236pubmed: 26664990google scholar: lookup
  2. Ellis DS, Shirodaria PV, Fleming E, Simpson DI. Morphology and development of Rift Valley fever virus in Vero cell cultures.. J Med Virol 1988 Feb;24(2):161-74.
    doi: 10.1002/jmv.1890240205pubmed: 3280732google scholar: lookup
  3. Swanepoel R, Coetzer JAW. Rift valley fever. .
  4. Martin V, Chevalier V, Ceccato P, Anyamba A, De Simone L, Lubroth J, de La Rocque S, Domenech J. The impact of climate change on the epidemiology and control of Rift Valley fever.. Rev Sci Tech 2008 Aug;27(2):413-26.
    doi: 10.20506/rst.27.2.1802pubmed: 18819669google scholar: lookup
  5. Rweyemamu M, Kambarage D, Karimuribo E, Wambura P, Matee M, Kayembe JM, Mweene A, Neves L, Masumu J, Kasanga C, Hang'ombe B, Kayunze K, Misinzo G, Simuunza M, Paweska JT. Development of a One Health National Capacity in Africa : the Southern African Centre for Infectious Disease Surveillance (SACIDS) One Health Virtual Centre Model.. Curr Top Microbiol Immunol 2013;366:73-91.
    doi: 10.1007/978-3-662-45791-7_244pubmed: 22820706google scholar: lookup
  6. Anyamba A, Linthicum KJ, Tucker CJ. Climate-disease connections: Rift Valley Fever in Kenya.. Cad Saude Publica 2001;17 Suppl:133-40.
  7. Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases.. Trans R Soc Trop Med Hyg 2009 Feb;103(2):109-21.
  8. Pepin M, Bouloy M, Bird BH, Kemp A, Paweska J. Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.. Vet Res 2010 Nov-Dec;41(6):61.
    doi: 10.1051/vetres/2010033pmc: PMC2896810pubmed: 21188836google scholar: lookup
  9. Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus.. Antiviral Res 2012 Sep;95(3):293-310.
  10. Opayele AV, Odaibo GN, Olaleye OD. Rift valley fever virus infection among livestock handlers in Ibadan, Nigeria.. J Immunoassay Immunochem 2018;39(6):609-621.
    doi: 10.1080/15321819.2018.1525739pubmed: 30362911google scholar: lookup
  11. Olaleye OD, Tomori O, Ladipo MA, Schmitz H. Rift Valley fever in Nigeria: infections in humans.. Rev Sci Tech 1996 Sep;15(3):923-35.
    doi: 10.20506/rst.15.3.967pubmed: 9025142google scholar: lookup
  12. Boushab BM, Fall-Malick FZ, Ould Baba SE, Ould Salem ML, Belizaire MR, Ledib H, Ould Baba Ahmed MM, Basco LK, Ba H. Severe Human Illness Caused by Rift Valley Fever Virus in Mauritania, 2015.. Open Forum Infect Dis 2016 Oct;3(4):ofw200.
    doi: 10.1093/ofid/ofw200pmc: PMC5106018pubmed: 27844026google scholar: lookup
  13. Moiane B, Mapaco L, Thompson P, Berg M, Albihn A, Fafetine J. High seroprevalence of Rift Valley fever phlebovirus in domestic ruminants and African Buffaloes in Mozambique shows need for intensified surveillance.. Infect Ecol Epidemiol 2017;7(1):1416248.
  14. Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Depner K, Drewe JA, Garin-Bastuji B, Rojas JLG, Schmidt CG, Michel V, Chueca MÁM, Roberts HC, Sihvonen LH, Stahl K, Calvo AV, Viltrop A, Winckler C, Bett B, Cetre-Sossah C, Chevalier V, Devos C, Gubbins S, Monaco F, Sotiria-Eleni A, Broglia A, Abrahantes JC, Dhollander S, Stede YV, Zancanaro G. Rift Valley Fever - epidemiological update and risk of introduction into Europe.. EFSA J 2020 Mar;18(3):e06041.
    doi: 10.2903/j.efsa.2020.6041pmc: PMC7527653pubmed: 33020705google scholar: lookup
  15. Bishop DH, Calisher CH, Casals J, Chumakov MP, Gaidamovich SY, Hannoun C, Lvov DK, Marshall ID, Oker-Blom N, Pettersson RF, Porterfield JS, Russell PK, Shope RE, Westaway EG. Bunyaviridae.. Intervirology 1980;14(3-4):125-43.
    doi: 10.1159/000149174pubmed: 6165702google scholar: lookup
  16. Gerdes GH. Rift Valley fever.. Rev Sci Tech 2004 Aug;23(2):613-23.
    doi: 10.20506/rst.23.2.1500pubmed: 15702723google scholar: lookup
  17. Food and Agriculture Organization (FAO). Rift Valley Fever: Transmission and spread. Causes of Transmission. Rome, Italy: FAO; 2010.
  18. Paweska JT. Rift Valley fever.. Rev Sci Tech 2015 Aug;34(2):375-89.
    doi: 10.20506/rst.34.2.2364pubmed: 26601442google scholar: lookup
  19. Shoemaker TR, Nyakarahuka L, Balinandi S, Ojwang J, Tumusiime A, Mulei S, Kyondo J, Lubwama B, Sekamatte M, Namutebi A, Tusiime P, Monje F, Mayanja M, Ssendagire S, Dahlke M, Kyazze S, Wetaka M, Makumbi I, Borchert J, Zufan S, Patel K, Whitmer S, Brown S, Davis WG, Klena JD, Nichol ST, Rollin PE, Lutwama J. First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years.. Am J Trop Med Hyg 2019 Mar;100(3):659-671.
    doi: 10.4269/ajtmh.18-0732pmc: PMC6402942pubmed: 30675833google scholar: lookup
  20. Food and Agriculture Oorganization FAO/OIE/WHO. Africa—el niño and increased risk of Rift valley fever—warning to countries. EMPRES WATCH 2015;34.
  21. World Health Organization. Rift Valley Fever in Niger. WHO Outbreak Report Geneva, Switzerland: World Health Organization; 2016. pp. 1–4.
  22. ProMED. Rift Valley Fever—Niger (03): (Tahoua), Livestock, Human. 2016.
  23. Ferguson W. Identification of Rift valley fever in Nigeria. Bulletin Of Epizootic Diseases of Africa 1959;7:317–318.
  24. Fagbami A, Tomori O, Kemp G. A survey of Nigerian domestic and wild animals for serum neutralising antibody to indigenous Rift Valley fever virus. Nigerian Veterinary Journal 1973;2(2):45–48.
  25. Ezeifeka GO, Umoh JU, Belino ED, Ezeokoli CD. A serological survey for Rift Valley fever antibody in food animals in Kaduna and Sokoto States of Nigeria.. Int J Zoonoses 1982 Dec;9(2):147-51.
    pubmed: 6820360
  26. Olaleye OD, Tomori O, Schmitz H. Rift Valley fever in Nigeria: infections in domestic animals.. Rev Sci Tech 1996 Sep;15(3):937-46.
    doi: 10.20506/rst.15.3.966pubmed: 9025143google scholar: lookup
  27. Alhaji NB, Babalobi OO, Wungak Y, Ularamu HG. Participatory survey of Rift Valley fever in nomadic pastoral communities of North-central Nigeria: The associated risk pathways and factors.. PLoS Negl Trop Dis 2018 Oct;12(10):e0006858.
  28. Adamu AM, Enem SI, Ngbede EO, Owolodun OA, Dzikwi AA, Ajagbe OA, Datong DD, Bello GS, Kore M, Yikawe SS, Allam L, Simon AY. Serosurvey on Sheep Unravel Circulation of Rift Valley Fever Virus in Nigeria.. Ecohealth 2020 Sep;17(3):393-397.
    doi: 10.1007/s10393-020-01490-zpubmed: 33106981google scholar: lookup
  29. Adamu AM, Allam L, Sackey AKB, Nma AB, Mshelbwala PP, Machunga-Mambula S, Idoko SI, Adikwu AA, Nafarnda WD, Garba BS, Owolodun OA, Dzikwi AA, Balogun EO, Simon AY. Risk factors for Rift Valley fever virus seropositivity in one-humped camels (Camelus dromedarius) and pastoralist knowledge and practices in Northern Nigeria.. One Health 2021 Dec;13:100340.
  30. Tomori O. Rift Valley fever virus infection in man in Nigeria.. J Med Virol 1980;5(4):343-50.
  31. Bukbuk DN, Fukushi S, Tani H, Yoshikawa T, Taniguchi S, Iha K, Fukuma A, Shimojima M, Morikawa S, Saijo M, Kasolo F, Baba SS. Development and validation of serological assays for viral hemorrhagic fevers and determination of the prevalence of Rift Valley fever in Borno State, Nigeria.. Trans R Soc Trop Med Hyg 2014 Dec;108(12):768-73.
    pmc: PMC7107251pubmed: 25344695doi: 10.1093/trstmh/tru163google scholar: lookup
  32. Alhaji NB, Aminu J, Lawan MK, Babalobi OO, Ghali-Mohammed I, Odetokun IA. Seropositivity and associated intrinsic and extrinsic factors for Rift Valley fever virus occurrence in pastoral herds of Nigeria: a cross sectional survey.. BMC Vet Res 2020 Jul 14;16(1):243.
    doi: 10.1186/s12917-020-02455-8pmc: PMC7359261pubmed: 32664958google scholar: lookup
  33. Karesh WB, Cook RA, Bennett EL, Newcomb J. Wildlife trade and global disease emergence.. Emerg Infect Dis 2005 Jul;11(7):1000-2.
    doi: 10.3201/eid1107.050194pmc: PMC3371803pubmed: 16022772google scholar: lookup
  34. Olive MM, Goodman SM, Reynes JM. The role of wild mammals in the maintenance of Rift Valley fever virus.. J Wildl Dis 2012 Apr;48(2):241-66.
    doi: 10.7589/0090-3558-48.2.241pubmed: 22493102google scholar: lookup
  35. Britch SC, Binepal YS, Ruder MG, Kariithi HM, Linthicum KJ, Anyamba A, Small JL, Tucker CJ, Ateya LO, Oriko AA, Gacheru S, Wilson WC. Rift Valley fever risk map model and seroprevalence in selected wild ungulates and camels from Kenya.. PLoS One 2013;8(6):e66626.
  36. Clark MHA, Warimwe GM, Di Nardo A, Lyons NA, Gubbins S. Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016.. PLoS Negl Trop Dis 2018 Jul;12(7):e0006627.
  37. Odunlami S, Lake B. An assessment of the ecotourism potential of Yankari national park, Nigeria. Eco Club. Communication E paper Series NR 2003;7.
  38. Atuman Y, Adawa Y, Solomon A, Mshelbwala P, Ogunkoya A. Potential risks for rabies spill-over from apparently healthy dogs to wildlife in Bauchi State, Nigeria. Journal of Veterinary Advances 2014;4(4):493–498.
  39. National Bureau of Statistics. Demographic Statistics Bulletin. 2017.
  40. Daszak P, Cunningham AA, Hyatt AD. Emerging infectious diseases of wildlife--threats to biodiversity and human health.. Science 2000 Jan 21;287(5452):443-9.
    doi: 10.1126/science.287.5452.443pubmed: 10642539google scholar: lookup
  41. Bengis RG, Kock RA, Fischer J. Infectious animal diseases: the wildlife/livestock interface.. Rev Sci Tech 2002 Apr;21(1):53-65.
    pubmed: 11974630doi: 10.20506/rst.21.1.1322google scholar: lookup
  42. Gortazar C, Diez-Delgado I, Barasona JA, Vicente J, De La Fuente J, Boadella M. The Wild Side of Disease Control at the Wildlife-Livestock-Human Interface: A Review.. Front Vet Sci 2014;1:27.
    doi: 10.3389/fvets.2014.00027pmc: PMC4668863pubmed: 26664926google scholar: lookup
  43. Ibrahim S, Danbirni S, Usman A. Preliminary study on the prevalence of bovine tuberculosis and risk factors among pastoralists in Gombe State, North Eastern Nigeria. J Microbiol Exp 2016;3(1).
  44. Fafetine JM, Coetzee P, Mubemba B, Nhambirre O, Neves L, Coetzer JA, Venter EH. Rift Valley Fever Outbreak in Livestock, Mozambique, 2014.. Emerg Infect Dis 2016 Dec;22(12):2165-2167.
    pmc: PMC5189134pubmed: 27869589doi: 10.3201/eid2212.160310google scholar: lookup
  45. van den Bergh C, Venter EH, Swanepoel R, Thompson PN. High seroconversion rate to Rift Valley fever virus in cattle and goats in far northern KwaZulu-Natal, South Africa, in the absence of reported outbreaks.. PLoS Negl Trop Dis 2019 May;13(5):e0007296.
  46. Lichoti JK, Kihara A, Oriko AA, Okutoyi LA, Wauna JO, Tchouassi DP, Tigoi CC, Kemp S, Sang R, Mbabu RM. Detection of rift valley Fever virus interepidemic activity in some hotspot areas of kenya by sentinel animal surveillance, 2009-2012.. Vet Med Int 2014;2014:379010.
    doi: 10.1155/2014/379010pmc: PMC4147350pubmed: 25202470google scholar: lookup
  47. Magona JW, Galiwango T, Walubengo J, Mukiibi G. Rift Valley fever in Uganda: seroprevalence and risk factor surveillance vis-a-vis mosquito vectors, anti-RVF virus IgG and RVF virus neutralizing antibodies in goats. Small Ruminant Research 2013;114(1):176–181.
  48. Abdulkarim MA, Babale SM, Umeokonkwo CD, Bamgboye EA, Bashorun AT, Usman AA, Balogun MS. Epidemiology of Lassa Fever and Factors Associated with Deaths, Bauchi State, Nigeria, 2015-2018.. Emerg Infect Dis 2020 Apr;26(4):799-801.
    pmc: PMC7101116pubmed: 32186504doi: 10.3201/eid2604.190678google scholar: lookup
  49. Evans A, Gakuya F, Paweska JT, Rostal M, Akoolo L, Van Vuren PJ, Manyibe T, Macharia JM, Ksiazek TG, Feikin DR, Breiman RF, Kariuki Njenga M. Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife.. Epidemiol Infect 2008 Sep;136(9):1261-9.
    pmc: PMC2870911pubmed: 17988425doi: 10.1017/s0950268807009806google scholar: lookup
  50. Anderson EC, Rowe LW. The prevalence of antibody to the viruses of bovine virus diarrhoea, bovine herpes virus 1, rift valley fever, ephemeral fever and bluetongue and to Leptospira sp in free-ranging wildlife in Zimbabwe.. Epidemiol Infect 1998 Oct;121(2):441-9.
    pmc: PMC2809544pubmed: 9825798doi: 10.1017/s0950268898001289google scholar: lookup
  51. Capobianco Dondona A, Aschenborn O, Pinoni C, Di Gialleonardo L, Maseke A, Bortone G, Polci A, Scacchia M, Molini U, Monaco F. Rift Valley Fever Virus among Wild Ruminants, Etosha National Park, Namibia, 2011.. Emerg Infect Dis 2016 Jan;22(1):128-30.
    doi: 10.3201/eid2201.150725pmc: PMC4696689pubmed: 26692385google scholar: lookup
  52. Gortazar C, Diez-Delgado I, Barasona JA, Vicente J, De La Fuente J, Boadella M. The Wild Side of Disease Control at the Wildlife-Livestock-Human Interface: A Review.. Front Vet Sci 2014;1:27.
    pmc: PMC4668863pubmed: 26664926doi: 10.3389/fvets.2014.00027google scholar: lookup
  53. Brown C. Emerging zoonoses and pathogens of public health significance--an overview.. Rev Sci Tech 2004 Aug;23(2):435-42.
    pubmed: 15702711doi: 10.20506/rst.23.2.1495google scholar: lookup

Citations

This article has been cited 2 times.
  1. Sulaimon TA, Chaters GL, Nyasebwa OM, Swai ES, Cleaveland S, Enright J, Kao RR, Johnson PCD. Modeling the effectiveness of targeting Rift Valley fever virus vaccination using imperfect network information.. Front Vet Sci 2023;10:1049633.
    doi: 10.3389/fvets.2023.1049633pubmed: 37456963google scholar: lookup
  2. Dzikwi-Emennaa AA, Meseko C, Emennaa P, Adeyinka AJ, Adamu AM, Adegboye OA. Detection of Crimean-Congo Hemorrhagic Fever Virus Antibodies in Cattle in Plateau State, Nigeria.. Viruses 2022 Nov 24;14(12).
    doi: 10.3390/v14122618pubmed: 36560622google scholar: lookup